Jinshan

Chongqing Jinshan Science & Technology launched China’s first domestically developed capsule endoscope in 2004 according to the company’s own profile, an early entry into wireless endoscopy that was previously dominated by foreign products. Jinshan reports distribution across more than 100 countries through over 6,000 medical institutions; specific Chinese market share figures vary by source and are not publicly verified here.

Company Overview

Founded in 1998, Jinshan built its technical foundation on MEMS (Micro-Electro-Mechanical Systems) technology, establishing dedicated academician and doctoral workstations to support research initiatives. The company has participated in numerous national-level programs including the “863 High-Tech Program” and National Science and Technology Cooperation Program, accumulating over 1,300 patents.

Jinshan holds multiple national designations including “Specialized, Refined, Differentiated, and New Little Giant” enterprise status from the Ministry of Industry and Information Technology. In 2022, the company was selected as the lead organization for the “AI Medical Device Innovation Task” jointly designated by MIIT and NMPA.

The company operates from a 60,000 square meter headquarters campus in Chongqing’s Yubei District, employing over 650 staff with research and development investment consistently at 15-20% of annual revenue.

Core Products

OMOM RC Capsule Robot System

The RC100 represents Jinshan’s flagship capsule robot platform, featuring fully automated magnetic navigation for gastric and small bowel examination. The system received CE Mark certification in May 2021 and NMPA approval in September 2021. Clinical validation published in The Lancet Gastroenterology & Hepatology demonstrated 97%+ concordance with conventional gastroscopy in a dual-center prospective study.

OMOM HD Capsule Endoscopy Platform

The high-definition small bowel capsule system features 512×512 pixel resolution (300%+ improvement over previous generation), 172-degree ultra-wide viewing angle, SpeedSense adaptive frame rate (2-10 FPS), and 12-hour battery life. The Vue Smart AI-powered software platform provides automated lesion detection and up to 90% redundancy deletion.

OMOM CC Colon Capsule System

A dual-lens colon capsule with 344-degree combined field of view, intelligent variable frame rate (4-35 FPS), and 15-hour operating time designed as a non-invasive alternative to traditional colonoscopy.

Gastrointestinal Motility Diagnostics

The alpHaONE wireless pH capsule monitoring system and alpHaFLEX impedance-pH combination system provide broad reflux diagnostics with up to 96-hour continuous monitoring capability.

Electronic Endoscopy & Surgical Energy

The VE260 high-definition electronic gastroenteroscope and JSDD-Q2 argon plasma coagulation system round out Jinshan’s GI diagnostic and therapeutic portfolio.

Technology & Innovation

Jinshan’s competitive advantage centers on MEMS miniaturization technology enabling progressively smaller, more capable capsule devices. The company pioneered bidirectional RF communication in capsule endoscopy, allowing real-time adjustment of image capture rate and light intensity during examination.

The 2020 launch of the “Three Musketeers” capsule series (NCG100 gastric, SC100 small bowel, NC100 pan-enteric) established Jinshan’s multi-segment coverage strategy. The subsequent RC100 capsule robot introduced fully autonomous navigation, eliminating operator dependence in capsule positioning.

AI integration through the Vue Smart platform represents ongoing investment in diagnostic intelligence, with algorithms trained to identify and classify 16 types of gastrointestinal abnormalities.

Market Presence

Jinshan dominates the Chinese capsule endoscopy market with approximately 95% domestic market share. The company reports 35-50% share of international capsule endoscopy volume outside the Given Imaging/Medtronic ecosystem.

Products entered the United Nations procurement directory in 2007 and achieved Chinese national medical insurance coverage starting from Chongqing in 2008, subsequently expanding nationwide. Current global reach spans over 100 countries with installations in more than 6,000 medical institutions.

Strategic partnerships include collaboration with China Academy of Sciences Institute of Automation for AI medical imaging research, and integration with China Unicom and Huawei 5G infrastructure for telemedicine capabilities.

Key Milestones

• 1998: Company founded in Chongqing
• 2004: Developed China’s first capsule endoscope
• 2005: OMOM capsule endoscopy system launched commercially
• 2007: Entered UN procurement directory; received CE Mark certification
• 2008: First Chinese province (Chongqing) to include capsule endoscopy in medical insurance
• 2010: Won Global Grand Prize at UK Innovation Technology International Challenge
• 2020: Launched OMOM HD “Three Musketeers” capsule series
• 2021: RC100 fully automated capsule robot received CE (May) and NMPA (September) approvals; research published in The Lancet
• 2022: Designated lead organization for national AI medical device innovation initiative

Frequently Asked Questions

What products does Jinshan offer?

Jinshan provides broad gastrointestinal diagnostic solutions including the OMOM series capsule endoscopes (small bowel HD, colon, gastric magnetic control, and fully automated robot), pH and impedance reflux monitoring systems, electronic gastroenteroscopes, argon plasma coagulation systems, and hysteroscopic surgical platforms.

Does Jinshan have FDA approval?

The OMOM small bowel capsule endoscopy system has received FDA clearance. However, the newer magnetically controlled capsule gastroscopy systems (RC100 robot) and colon capsule have CE Mark and NMPA approvals but have not yet received FDA clearance.

How does OMOM compare to PillCam?

Both systems provide comparable diagnostic yields for small bowel pathology detection. OMOM offers cost advantages (approximately 50% lower than PillCam in China market) and unique features including magnetically controlled gastric examination capability not available in the standard PillCam SB product line.